[Peripheral blood stem cell transplantation: current status and perspectives]

Area of Science:

• Hematology
• Transplantation Medicine
• Oncology

Background:

• Peripheral blood stem cell (PBSC) transplantation is a prevalent method for stem cell transplantation.
• While effective for short-term engraftment, optimal mobilization techniques and the role of growth factors remain unclear.
• The addition of bone marrow stem cells and comparative long-term outcomes versus traditional bone marrow transplantation require further investigation.

Purpose of the Study:

• To highlight the need for comparative trials evaluating bone marrow transplantation (BMT) and PBSC transplantation for long-term engraftment and anti-tumoral effects.
• To address the inadequacy of current methods for estimating circulating hematopoietic progenitors after mobilization.
• To emphasize the variability of immature progenitor cells based on chemotherapy and growth factor regimens.

Main Methods:

• Review of current practices and existing literature on PBSC transplantation.
• Discussion of the limitations of colony-forming unit-granulocyte-macrophage (CFU-GM) and CD34+ cell counts for assessing progenitor cell efficacy.
• Identification of key areas for future comparative clinical trials.

Main Results:

• PBSC transplantation demonstrates efficacy in short-term engraftment.
• Existing methods (CFU-GM, CD34+ levels) are insufficient to accurately estimate immature hematopoietic progenitor cells.
• Mobilization strategies significantly influence the levels of circulating progenitor cells.

Conclusions:

• Comparative trials are essential to determine the optimal stem cell transplantation approach, focusing on long-term engraftment and anti-tumoral efficacy.
• More reliable methods are needed to quantify circulating hematopoietic progenitors for effective patient management.
• Understanding the impact of mobilization protocols on progenitor cell populations is crucial for improving transplantation outcomes.